Introduction: Liposarcomas are malignant tumors derived from fat tissues. Liposarcoma of the paratesticular tissue is rare.
Case Report: We presented a 51-year-old man with liposarcoma of paratesticular tissue and the spermatic cord, mimicking a testicular tumor. Ultrasound examination of this scrotal mass was hyperechogenic and homogeneous and separated from the testis and epididymis. The patient was operated, and the orchidectomy was performed. Histology revealed well-differentiated lipoma-like liposarcoma of the paratesticular tissue and spermatic cord. After a 6 month follow-up the patient did not show any evidence of tumor-progression or recurrence.
Conclusion: Liposarcomas of the paratesticular tissue and seminal cord represent a rare type of tumors, often misdiagnosed preoperatively. Therapy should include radical surgical excision, usually radical inguinal orchiectomy. If the margin status is in doubt, adjuvant radiation should be performed. Local relapse is common and may occur after several years, so follow-up period has to be sufficiently long.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.2298/vsp1307695v | DOI Listing |
Georgian Med News
November 2024
Department of Surgery, College of Medicine, Qassim University, Buraydah, Saudi Arabia.
Splenogonadal fusion is a rare congenital anomaly characterized by an unusual linkage between ectopic splenic tissue and the gonad, with a higher prevalence observed in the males. While the majority of the splenogonadal fusion cases are associated with cryptorchidism, the patients may have other congenital malformations such as inguinal hernias. Despite being benign and having a rare occurrence, the preoperative diagnosis of splenogonadal fusion is a challenging one.
View Article and Find Full Text PDFAnn Surg Oncol
December 2024
Soft Tissue Sarcoma Surgery, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy.
Spermatic cord sarcomas (SCS) are a group of mesenchymal tumors whose rarity and anatomical location often lead to clinical misdiagnosis such as inguinal hernia, testicular tumor, or other conditions. Any inguinoscrotal mass with suspicious characteristics should prompt clinicians to perform imaging assessments (such as ultrasound or, in uncertain cases, magnetic resonance imaging (MRI)) and refer the patient promptly to a specialized center. Histological characterization of all suspicious masses via percutaneous biopsy is recommended, with staging completed through computed tomography (CT) scan for confirmed cases.
View Article and Find Full Text PDFCureus
October 2024
Pathology and Laboratory Medicine, Albert Einstein College of Medicine, Bronx, USA.
Cureus
October 2024
Oncology, Pontifícia Universidade Católica Do Rio Grande Do Sul, Porto Alegre, BRA.
Rhabdomyosarcomas, malignant mesenchymal tumors of skeletal striated muscle tissue cells, are usually rare in adults. However, when they occur in this population, the prognosis is usually poor, especially if the condition is associated with molecular factors such as the PAX3-FOXO1 fusion. Here, We report a case of paratesticular alveolar rhabdomyosarcoma in an adult patient who initially complained of increased scrotal volume for two years and presented with a PAX3-FOXO1 fusion.
View Article and Find Full Text PDFJ Pediatr Surg
February 2025
Department of Urology, Division of Pediatric Urology, University of Kentucky, Lexington, KY, USA. Electronic address:
Background: Treatment strategies for paratesticular rhabdomyosarcoma (PT RMS) are based on stage, which requires accurate lymph node (LN) evaluation. Previous methodology for determining quantity of LN for negative nodal status is based on LN positivity rates, without accounting for the relationship between LNs or amongst patients. This study aims to quantify the chance of missing involved LNs based on LN yield (LNY) using a previously established methodology in comparison to current recommendations.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!